Skip to content

Three IPOs to hit Dalal Street tomorrow, total fund raising over Rs 1,600 crore

Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment.

Read More

​ Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment. Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish